Titan Pharmaceuticals, Inc. Operating Loss Carryforwards
Titan Pharmaceuticals, Inc. had Operating Loss Carryforwards of $8.80 million as of 2018-12-31, per its 10-K/A filed 2019-04-02.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2019-04-02
- 2018-12-31: Operating Loss Carryforwards $8.80M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2018-12-31 | $8.80M 10-K/A · filed 2019-04-02 |